KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Working Capital Changes (2020 - 2025)

Historic Other Working Capital Changes for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to -$997000.0.

  • Aurinia Pharmaceuticals' Other Working Capital Changes fell 15878.54% to -$997000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year increase of 40598.29%. This contributed to the annual value of $5.8 million for FY2024, which is 23159.81% up from last year.
  • Aurinia Pharmaceuticals' Other Working Capital Changes amounted to -$997000.0 in Q3 2025, which was down 15878.54% from $11.2 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Other Working Capital Changes ranged from a high of $11.2 million in Q2 2025 and a low of -$7.3 million during Q4 2023
  • Its 5-year average for Other Working Capital Changes is $462117.6, with a median of -$307000.0 in 2022.
  • Over the last 5 years, Aurinia Pharmaceuticals' Other Working Capital Changes had its largest YoY gain of 46221.61% in 2023, and its largest YoY loss of 166464.89% in 2023.
  • Over the past 5 years, Aurinia Pharmaceuticals' Other Working Capital Changes (Quarter) stood at -$1.2 million in 2021, then skyrocketed by 65.75% to -$413000.0 in 2022, then tumbled by 1664.65% to -$7.3 million in 2023, then soared by 97.09% to -$212000.0 in 2024, then crashed by 370.28% to -$997000.0 in 2025.
  • Its Other Working Capital Changes stands at -$997000.0 for Q3 2025, versus $11.2 million for Q2 2025 and -$6.0 million for Q1 2025.